Background: Degenerative features, such as neuronal, glial, synaptic and axonal loss, have been identified in neocortical and other grey matter structures in patients with multiple sclerosis, but mechanisms for neurodegeneration are unclear. Cortical demyelinating lesions are a potential cause of this degeneration, but the pathological and clinical significance of these lesions is uncertain as they remain difficult to identify and study in vivo. In this study we aimed to describe and quantify cellular and subcellular pathology in the cortex of myelin oligodendrocyte glycoprotein-induced marmoset experimental autoimmune encephalomyelitis using quantitative immunohistochemical methods. Results: We found evidence of diffuse axonal damage occurring throughout cortical grey matter with evidence for synaptic loss and gliosis and a 13.6% decrease in neuronal size and occurring in deep cortical layers. Evidence of additional axonal damage and a 29.6-36.5% loss of oligodendrocytes was found in demyelinated cortical lesions. Leucocortical lesions also showed neuronal loss of 22.2% and a 15.8% increase in oligodendrocyte size. Conclusions: The marmoset experimental autoimmune encephalomyelitis model, therefore, shows both focal and generalized neurodegeneration. The generalized changes cannot be directly related to focal lesions, suggesting that they are either a consequence of diffusible inflammatory factors or secondary to remote lesions acting through trans-synaptic or retrograde degeneration.
Introduction
Cortical demyelination has long been recognised in multiple sclerosis (MS), 1 but until recently the extent has been underestimated due to difficulties in identifying cortical lesions using conventional neuropathological and radiological techniques. Immunohistochemical studies have shown widespread demyelination in MS cortex, occupying a mean of 9-26.5% and a median of 3-14% of the total cortical area. [2] [3] [4] Focal demyelinating cortical lesions are distinct from white matter lesions in terms of their morphology and inflammatory cell content. Leucocortical lesions involve the white matter and also the deeper layers of the cortex, intracortical lesions are small, round or ovoid in shape and are centred on a blood vessel. Larger subpial lesions are found that run parallel to the pial surface and can stretch across a whole gyrus or across multiple gyri. 5 All cortical lesion subtypes contain a lower density of inflammatory cells compared with white matter lesions, whilst subpial lesions have been shown to contain a similar lymphocyte density compared with control cortex. 6 Cortical lesions are difficult to detect in vivo 7 and clinical-pathological correlations are thus uncertain. More extensive cortical demyelination has been associated with the progressive phases of MS where degenerative features of axonal loss and cerebral atrophy are more extensive. 8, 9 Such features have shown only moderate or poor correlations with the extent of traditional white matter lesions in MS. [8] [9] [10] [11] Neuropathological studies have characterized neurodegenerative features in cortical lesions and found evidence of neuronal glial and synaptic loss in leucocortical lesions 12 and neuronal loss in subpial lesions in two patients with extensive cortical demyelination. 4 However, interpretation and study of the MS brain is limited by problems with suboptimal fixation and a shortage of pathological material in the early active stages of disease.
Animal models offer an alternative approach to understanding the relationship between myelin-directed autoimmunity and neurodegeneration. Cortical lesions have been described in myelin oligodendrocyte glycoprotein (MOG)-induced marmoset experimental autoimmune encephalomyelitis (EAE) and in Lewis rats, which share the essential characteristics of lesions in MS. Similar morphological subtypes to those in MS have been described and subpial lesions have been found to be the most frequent lesion subtype and to have the lowest density of inflammatory cells. [13] [14] [15] [16] [17] [18] We have previously described diffuse cortical atrophy in this model but, as in MS, the mechanism responsible for the atrophy has not been defined. 16 Limited evidence of neurodegenerative features in the form of axonal damage and single neurons undergoing apoptosis has been seen in focal lesions of thee Lewis rat that were induced by stereotactic injection of proinflammatory mediators. 17 The aim of the current study is to provide a detailed, quantitative description of neurodegenerative features in myelinated and demyelinated cortex to provide new evidence relevant to the underlying mechanisms.
Methods

Disease model
Tissue was acquired from six animals with EAE and five control animals all of which came from an outbred colony of common marmosets (Callithrix jacchus jacchus) kept as part of an approved animal care and use protocol at the National Institutes of Health, Washington, USA. Animals were induced with EAE through a subcutaneous injection of MOG and inactivated Bordetella pertussis. EAE animals underwent a progressive relapsing disease course with survival times of 26-70 days. Whole brains were cut into 2-mm thick sections using a brain frame and sectioned at 6 mm using a sliding microtome. Full clinical data and details of tissue selection and immunohistochemical methods have been provided elsewhere. 13 
Identification of lesions and matched control areas
Reference sections from all tissue blocks were stained for myelin using anti-PLP (Serotec, UK) in order to identify demyelinated cortical lesions. Sequential sections were taken from either side of the reference section and stained with antibodies against neurones (anti-NeuN, Serotec, UK) and astrocytes (anti-GFAP (glial fibrillary acidic protein), Dako, UK). A further adjacent section was stained with antibodies against oligodendrocytes (anti-CA2, Serotec, UK). Anti-CA2 has previously been shown to label approximately 20-30% of the cells that fit morphological criteria for identification as oligodendrocytes in MS lesions, whereas anti-2 0 ,3 0 -cyclic nucleotide 3 0 -phosphodiesterase (CNPase) labelled only 5-10%. 19 All sections used in this procedure were cut and stained in the same session. This process was repeated with a new reference section surrounded by sequential sections stained for axonal damage (antibAPP (b-amyloid precursor protein), Serotec, UK) and synapses (anti-synaptophysin, Dako, UK)
Lesions were identified on myelin-stained sections and were classified according to the morphological classification described by Peterson et al. 5 A threedimensional coordinate was calculated for each lesion using a stereotaxic atlas of the marmoset brain. 20 Lesions were viewed using an Olympus BX41 microscope (Olympus, UK) at a magnification of Â100 and photographed using an AxioCam MRC5 camera (Carl Zeiss Microimaging, Germany) at a resolution of 2584 Â 1936 pixels. The border of each lesion was outlined using AxioVision 4.4 software (Imaging Associates, UK) to generate a template that was used to identify lesions and control areas on sequential sections. Care was taken to ensure that lesion templates included only deep cortical layers 5 and 6 for leucocortical lesions and only superficial cortical layers 1 and 2 for subpial lesions.
Matched control areas of normal-appearing grey matter (NAGM) and non-EAE control cortex were identified for each lesion. The procedure for selecting cortical areas from control blocks was repeated for each of the five staining protocols used, in order to minimise the effect of any individual control case. Due to variations in the characteristics of cortical lesions a different method was required to select control areas for each lesion subtype. All lesions were matched with an area of control cortex taken from an identical site in a non-EAE animal. Leucocortical lesions were matched with an area of NAGM taken from an identical position in the contralateral hemisphere. It was not possible to perform a direct comparison of subpial lesions with contralateral NAGM as subpial lesions almost exclusively occupied the cingulate region and were always bilateral. Instead, comparing an adjacent area of parasagittal NAGM with a matched area of non-EAE control cortex performed an indirect comparison. Using this method, features that were specific to demyelinated lesions would be expected to show a significant difference between lesions and control tissue but no difference between NAGM and control tissue.
Development of computer-assisted method for calculation of neuronal and oligodendrocyte parameters A rapid method of calculating cell size and cell density was designed and validated in a two-step process. Traditional manual cell counts were used to define cell size retrospectively and shape parameters and these parameters were subsequently used in a prospective validation of a semi-automated, computer-assisted counting method. It was not possible to count astrocytes in this way as gliosis in EAE animals was often quite extensive and it was not possible to outline individual cells.
The first stage of the validation process involved performing manual counts of cell size and shape in order to define cells in terms of these two parameters. A randomly selected subset of four lesions and four control areas was stained for myelin, oligodendrocytes and neurones as detailed above. Each region of interest (ROI) was visualized using an Olympus BH-2 microscope (Olympus UK) and a JVC KY-300 camera (JVC, UK). Each ROI was viewed in its entirety through a series of sequential high-powered fields (Â400). Live images of each field were viewed on a computer using KS400 image analysis software (Imaging associates, UK). All positive-staining structures within the field were outlined and their area and perimeter recorded. A structure was either classified as a 'cell body' if it possessed a ring of cytoplasm that completely encircled an intact nucleus, or a 'cell process' if it did not meet this morphological criterion. The area and F-circle value (shape) were calculated for all cell bodies and cell processes seen within the ROIs. For neurones, a cut-off point of area >60 mm 2 and F-circle >0.5 was chosen. This definition produced sensitivity for detecting 'cell bodies' of 89.5%, a specificity of 97.4% and a positive predictive value of 99.6%. For oligodendrocytes, a cut-off point of area >30 mm 2 and F-circle >0.5 was chosen. This definition produced a sensitivity of 98.9%, a specificity of 94.4% and a positive predictive value of 90.4%.
These definitions were used in a prospective analysis to compare cell densities obtained using manual and computer-assisted methods. The same subset of lesions and control areas were included in the computer counting method. Digital photographs were taken of each ROI at a magnification of Â100 using an Olympus BX41 microscope and an Olympus C-5050 digital camera (Olympus UK) at a resolution of 1280 Â 960 pixels. These pictures were converted to a greyscale image and viewed on a computer using Scion image for windows version 4.0.2 (Scion Corporation). Positive-staining particles were identified using a colour density threshold that was set individually for each image by increasing the threshold until just below the point at which background staining of myelin or cell nuclei began to appear in the image. The computer was programmed to identify all positively staining particles that fitted the size and shape parameters determined by the manual counting method. Figures obtained using manual and computer-assisted methods were compared using Pearson's correlation coefficient. Measures of cell density were corrected using the Abercrombie correction 21 in order to correct for biases in cell density caused by differences in cell size. Whilst the ratio between cell size and section thickness was too high to produce absolute measures of cell density, the use of this correction generated unbiased measures of relative cell density that could be compared between matched ROIs in this study.
Measurement of axonal and astrocyte parameters
ROIs stained with GFAP and bAPP were examined using a computer and a colour density threshold was applied as described above. An additional subset of deep white matter (WM) lesions was also identified in sections stained with bAPP by selecting the nearest focal WM lesion to each leucocortical lesion. The positive-staining area included above the colour density threshold was divided by the total area of the ROI to obtain the AreaPercentage. This figure therefore provided a measure of gliosis in sections stained with anti-GFAP or acute axonal damage in sections stained with anti-bAPP.
Measurement of synaptic density
A measure of relative synaptic density was obtained in sections stained with anti-synaptophysin by using microdensitometric techniques to record colour density within ROIs. When using a camera-based measure of optical density it is not possible to calibrate the system to a range of concentration standards and it is, therefore, not possible to give a figure for the absolute concentration of the target molecule being measured. However, it is still possible to obtain readings that are proportional to the concentration of the target antigen if it can be demonstrated that there is a linear response relationship within the range of optical densities of the ROIs being recorded. Prior to recording of optical density in histological sections the microscope and imaging system were both calibrated against a series of external international standards for optical density (OD) using a Kodak Photographic step tablet. All microscope settings and lighting conditions were kept constant throughout this calibration step and for all subsequent recordings of optical density. Linear regression analysis was performed to compare recorded optical density against true optical density and showed an almost perfect linear relationship with an r 2 -value of 0.995. ROIs were generated and digital images recorded using the methods described above. Images were greyscaled and viewed as an 8-bit image with a value of 255 representing white and a value of 0 representing black. The mean optical density of each ROI was recorded and divided by 255 to give a measure of light transmittance. This figure was converted to a measure of relative optical density (ROD) using the equation ROD ¼ log10 (1/grey level transmittance). The ratio between colour density in the grey and white matter was compared in order to control for background staining within each section. The figures reported are, therefore, measures of normalized optical density (NOD).
Statistical methods
Differences in cellular parameters and synaptic density were tested using a paired t-test with each ROI being compared with matched ROIs taken from lesions, NAGM and control cortex. This method eliminated the effects of physiological differences seen between different regions of the cortex. The distributions of rates of axonal damage were highly skewed and were therefore assessed using a non-parametric Mann-Whitney U-test. Intra-rate reliability was assessed in all counts by examining eight randomly selected ROIs using a blinded count-recount method and analysing the results using linear regression.
Control animals in this study were not age and sex matched and a possible confounding effect of these variables was assessed using linear regression analysis. Differences in recorded parameters between cases and controls were plotted against age differences between the animals. This produced a linear regression equation in the form y ¼ a + bx where 'a' is the difference in the recorded parameter at a theoretical point at which age is equal. A similar analysis was performed for differences in sex by giving male animals a nominal value of 1 and female animals a nominal value of 2. All statistical calculations were performed using SPSS software (version 12.0.1, SPSS Inc.)
Results
Cellular pathology in lesions and NAGM
Sections stained using antibodies against oligodendrocytes, astrocytes and neurones were assessed for any qualitative differences in staining patterns. No obvious disparities in cell morphology or density were seen in the intracortical lesions or in any of the three subpial lesions that did not involve the cingulate cortex. Anti-NeuN staining of neurones produced good quality staining of both the neuronal nuclei and cytoplasm ( Figure 1A,D) . Sections stained for oligodendrocytes with anti-CA2 showed prominent staining of cell bodies with less intense staining of myelin sheaths ( Figure 1B,E) . Oligodendrocyte density was lower in lesions than in adjacent NAGM ( Figure 1B) . Anti-GFAP staining of astrocyte cell bodies and processes generated a diffuse staining pattern throughout the neuropil ( Figure 1C,F) . Areas of mild astrocytosis could be seen within many leucocortical lesions, but the edges of these regions often spread out beyond the borders of demyelinated areas ( Figure 1C ). Several similar areas of astrocytosis were seen within the myelinated NAGM in deep cortical layers.
Quantitative size and shape parameters were recorded for cell bodies and cell fragments stained in four randomly selected lesions and four areas of NAGM using the manual counting method. Analysis using Pearson's correlation coefficient confirmed that the measures of cell density obtained using the manual and computer-assisted cell counting methods were highly correlated (NeuN:
Counting and recounting a subset of eight lesions for each stain assessed intra-rater reliability for the computer-assisted method. Pearson's correlation coefficients between counts and recounts were highly significant for both neurones (r 2 ¼ 0.937 p < 0.001) and oligodendrocytes (r 2 ¼ 0.857, p < 0.001). Data from 26 leucocortical lesions was included in the quantitative analysis of oligodendrocytes, 22 leucocortical lesions were analysed for neuronal and astrocyte pathology. This discrepancy in lesion numbers was due to the background staining of myelin sheaths in sections stained with anti-CA2 that facilitated more accurate identification of smaller demyelinated lesions. Fifteen cingulate subpial lesions were included in the quantitative analysis for all cell populations. The distribution of data for cell density, cell size and AreaPercentage was examined and was normally distributed. Data from matched lesions and control areas were therefore compared using a paired t-test. The mean and standard error for all cellular parameters in all cell types are shown for leucocortical and subpial lesions in Figures 2 and 3 respectively. All significant differences with a p-value <0.05 are highlighted in the graphs.
There was a decrease in oligodendrocyte staining in both leucocortical lesions (33% vs. control tissue p ¼ 0.03, 30% vs. NAGM p ¼ 0.03) and cingulate subpial lesions (36% vs. control tissue, p ¼ 0.03). Compared with control grey matter, there was an increase in relative GFAP staining in leucocortical lesions (263%, p ¼ 0.002), deep cortical NAGM (234%, p ¼ 0.005) and cingulate subpial lesions (143%, p ¼ 0.015), but not in superficial NAGM (59%, p ¼ 0.669). Significant neuronal size changes were only found in subpial plaques. In the superficial cortical layers there was a decrease in neuronal size in subpial lesions (À17.5% vs. controls, p < 0.001), a decreased neuronal size of similar magnitude was seen in NAGM of cortical layers 1 and 2 but this did not reach statistical significance (12.9%, p ¼ 0.055). In leucocortical lesions, similar decreases in neuronal size were found in both lesions (À16.2%, p ¼ 0.001) and NAGM (À13.6%, p ¼ 0.009). Neuronal density was reduced in leucocortical lesions (22.2% vs. NAGM p ¼ 0.023, 23.2% vs. controls p ¼ 0.045), but there was no evidence of neuronal loss detected in cingulate subpial lesions.
Linear regression analysis confirmed weak but significant correlations between neuronal density and age differences between cases and controls in both myelinated and demyelinated regions (r 2 ¼ 0.158-0.314). Other significant correlations were found between age and neuronal size in cingulate subpial lesions vs. controls (r 2 ¼ 0.593, p ¼ 0.020) and in oligodendrocyte size between leucocortical lesions and controls (r 2 ¼ 0.279, p ¼ 0.006). Examination of the constant in the regression equation revealed that the effect of age difference between cases and controls did not alter any of the conclusions regarding differences in cell size or density related to disease. There were no significant effects found between sex difference in cases and controls and any of the parameters measured.
Subcellular pathology in lesions and NAGM
Eighteen leucocortical lesions and 15 cingulate subpial lesions were identified in the sections used for analysis of axonal and synaptic pathology. An additional 18 deep WM lesions were used in the quantitative analysis of axonal damage. Visual inspection of the tissue revealed that bAPP staining was prominent throughout the WM of all cases, particularly in WM lesions but less prominent positive staining was seen in cortical lesions and in some areas of NAGM. Density of bAPP-positive staining was lower in regions of leucocortical lesions within the grey matter relative to extensions into the white matter portion whilst there was also less staining seen in cingulate subpial lesions compared with adjacent WM in the corpus callosum. bAPP staining appeared more prominent in deep WM lesions compared with cortical lesions. The distribution of bAPP positive axons within cingulate subpial lesions was concentrated towards the subpial surface. Axonal spheroids, indicative of axonal transection were rare in myelinated cortex, but were present in 5/15 subpial lesions and 9/18 leucocortical lesions. There was no bAPP-positive staining seen in control cases and control areas from non-EAE animals were therefore not included in the subsequent quantitative analysis. Typical appearances of bAPP staining in and around leucocortical and subpial lesions are shown in Figure 4A ,B.
Box and whisker plots showing the distribution of bAPP-positive axonal densities for WM lesions, cortical lesions and matched areas of WM and NAGM are shown in Figure 5 . The data were heavily skewed and required the use of a non-parametric Mann-Whitney U-test to assess relative densities between ROIs. Leucocortical lesions had a median density of 494.7 bAPP-positive axons/mm 2 which was significantly greater than that seen in matched areas of deep cortical NAGM (median ¼ 77.6, p ¼ 0.004). Cingulate subpial lesions had a median density of 51.3 axons/mm 2 which was significantly greater than that seen in areas of superficial NAGM from the paracentral cortex (median ¼ 11.7, p ¼ 0.003). Comparisons between unmatched ROIs revealed that leucocortical lesions had a significantly greater density of bAPP-positive axons than cingulate subpial lesions (p ¼ 0.006). The extent of bAPP-positive axons in grey matter (GM) overall, however, was lower than in WM lesions in these animals. Deep WM lesions had a median density of 1653.5 axons/mm 2 which showed only a trend towards significance when compared with leucocortical lesions (p ¼ 0.056) but was significantly greater than cingulate subpial lesions (p < 0.001). Sections stained using synaptophysin displayed high contrast between GM and WM. Examination of the GM at high power revealed a punctate staining pattern with lighter-staining shadows representing the position of cell bodies. WM in control cases was almost devoid of background staining but cases displayed distinct, small synaptophysin positive structures throughout the WM that were more frequent within lesions. These lesions were of similar size and shape to bAPP-positive structures. Typical appearances of sections stained for synaptophysin are shown in Figure 4C .
NOD of synaptophysin staining was quantified in 15 cingulate subpial lesions taken from five animals and 17 leucocortical lesions taken from six animals along with matched ROIs from five control animals. Leucocortical lesions had a mean NOD of 1.07 compared with 1.08 for NAGM and 1.14 for control cortex. A paired t-test confirmed a significant decrease in synaptophysin staining in lesions and NAGM compared with controls (p ¼ 0.001, p ¼ 0.006 respectively) but no significant difference between lesions and NAGM (p ¼ 0.380). Cingulate subpial lesions had a mean NOD of 1.10 compared with 1.12 for cingulate control cortex. Paracentral NAGM had a mean NOD of 1.09 compared with 1.13 for paracentral control cortex. A paired t-test did not find a significant difference in NOD between either cingulate lesions and controls or paracentral NAGM and controls (p ¼ 0.306, p ¼ 0.818 respectively. The bar charts in Figure 6 show the distribution of NOD measurements in all ROIs. A significant positive correlation was detected between age difference and NOD difference in cingulate subpial lesions and controls (r 2 ¼ 0.351, p ¼ 0.020). Analysis of the constant in the regression equation confirmed that this did not affect the conclusion that there was no significant effect of cingulate subpial lesions on synaptophysin NOD (a ¼ 0.025, p ¼ 0.480). There was no significant association between age and NOD difference for leucocortical lesions and no significant association between sex and difference in NOD in leucocortical or cingulate subpial lesions.
Discussion
This study has confirmed and extended a characterization of neurodegeneration in GM involving both cortical GM lesions and NAGM in MOG-induced marmoset EAE. Oligodendrocyte loss was specific to demyelinated lesions in the cortex whilst evidence of acute axonal damage was seen diffusely throughout the cortex but was more frequent in demyelinated lesions. The occurrence of other features differed between leucocortical and subpial lesions. There were no diffuse changes seen in myelinated areas of superficial cortex but gliosis and a decrease in neuronal size were found in cingulate subpial lesions. Gliosis, a decrease in neuronal size and synaptic loss were also seen diffusely throughout deep cortical layers whilst leucocortical lesions showed additional evidence of neuronal loss and an increase in oligodendrocyte size.
The finding of oligodendrocyte loss specific to demyelinated lesions makes intuitive sense and the magnitude of the loss witnessed in this study is similar to the 36% loss of glial cells seen in a previous study of MS. 12 The increase in oligodendrocyte size within leucocortical lesions could represent an increase in the number of reactive oligodendrocytes or oligodendrocyte precursor cells. Larger MOG +ve cells seen in MS lesions have been shown to be mature reactive oligodendrocytes 22 whilst studies of oligodendrocyte morphology in experimental cat lesions have shown that all oligodendrocyte precursor stages have relatively small nuclei and scant cytoplasm. 23, 24 This evidence suggests that the larger oligodendrocytes within lesions in this study are reactive.
Previous work in MS has shown that axonal loss occurs in the early disease course before significant disability has developed 8, 25 and at the time of a clinically isolated syndrome in MS or first relapse in EAE. 26, 27 Our finding of diffuse axonal damage in this model provides further evidence that axonal pathology occurs in the early active phase of demyelinating disease. Significantly greater rates of axonal damage were seen within demyelinated regions indicating that cortical demyelination contributes to axonal pathology.
The presence of axonal spheroids within lesions implies that a proportion of this damage is permanent and could contribute to the significant cortical atrophy that has been demonstrated in MS and marmoset EAE. 9, 11, 28 Evidence that inflammation is directly involved in axonal damage within the cortical lesions in this model derives from the finding that the more active leucocortical lesions contain higher rates of axonal damage than subpial lesions. In addition, bAPPpositive axons in subpial lesions were clustered close to the subarachnoid space which contains B-cells, T-cells and macrophages. Studies have shown that in EAE WM lesions and in MS cortical and WM lesions the degree of inflammation is proportional to the axonal damage in each lesion [29] [30] [31] [32] and that the precise location of axonal damage and inflammatory cell infiltration within individual lesions is closely linked. 33, 34 Axonal damage, synaptic loss and a decrease in neuronal size were all seen throughout myelinated and demyelinated areas of deep cortical layers but not in superficial layers. These features must therefore be due to more diffuse pathological factors or secondary to remote pathology in other areas of the CNS. Neurones in deep layers would be more vulnerable to effects of remote lesions due to their more extensive connections. Axonal pathology in remote white matter lesions could cause synaptic loss in deep cortical layers through Wallerian degeneration and a decrease in neuronal size through retrograde degeneration, which would be more likely to affect larger neurones with longer axons. Alternatively, diffuse changes can be caused by diffuse inflammation occurring throughout the whole brain and that has been described in MS. 3 We have previously demonstrated a greater concentration of inflammatory cells in NAGM of marmoset EAE compared with control animals and this background inflammation appears greater in deeper cortical layers. 13 The presence of inflammatory cells in the subarachnoid space overlying subpial lesions may also explain the similar findings of gliosis and a decrease in neuronal size that is specific to demyelinated lesions in superficial layers.
Comparisons can be drawn to assess whether this EAE model adequately reflects cortical pathology in MS. The lack of evidence for a reduction of synaptic density within cortical lesions in this study is consistent with a previous investigation of subpial lesions in MS, 4 but is different to the results of Wegner et al. who found a 47% loss of synaptophysin reactivity in MS leucocortical lesions. 12 The results of this study were potentially confounded by the staining pattern seen within lesions that was similar to that seen with bAPP and implies that synaptophysin accumulates in lesions due to interruption of fast axonal transport. This study may, therefore, have underestimated the extent of synaptic loss within lesions but it is unlikely that this issue explains a difference in synaptic density of this magnitude between MS and EAE.
Previous work in EAE spinal cord showed that synaptic and dendritic loss in the spinal cord was related to the degree of inflammation 35 and the discrepancy in findings in the cortex between MS and EAE is, therefore, surprising given that there is considerably more inflammation seen in EAE leucocortical lesions relative to those of MS. This discrepancy could be accounted for by differences in the age of lesions between chronic end-stage MS and the acute form of EAE in this study. The magnitude of synaptic loss in older lesions may reflect the build up of damage over time or a decreased capacity for cortical repair. Wegner et al. found evidence of a 50% increase in the concentration of GAP-43, a marker of synaptic plasticity within leucocortical lesions but it is conceivable that the capacity for synaptic repair is higher in the more acute EAE model. An alternative explanation is that there is a beneficial effect of inflammation similar to that seen in the taiep rat in which the induction of acute inflammation was required in order to remyelinate chronic demyelinated tissue. 36 These findings suggest that factors other than inflammation may be responsible for chronic synaptic loss.
Leucocortical lesions showed evidence of neuronal loss that was not seen in subpial lesions and this finding has previously been described in MS. Wegner et al. found an overall loss of neuronal density of 9% in leucocortical lesions compared with adjacent NAGM. 12 Vercellino et al. studied neuronal density in subpial lesions and found no significant difference in four out of six cases studied. 4 Although this group found evidence of neuronal loss in two patients, these patients had a degree of subpial demyelination (25-48%) that was far in excess of that seen in any of the marmosets in this study.
Neuronal loss could be caused by loss of trophic support from oligodendrocytes 37 but the magnitude of oligodendrocyte loss seen in this study was similar in leucocortical and subpial lesions. Neuronal loss therefore may occur as a direct result of inflammatory cell infiltration and previous studies in MS and EAE have shown more inflammatory activity in leucocortical lesions relative to subpial lesions. 2, 5, 13 The mechanism of inflammation has been shown to differ between cortical lesion types. Merkler et al. described immunoglobulin leakage and complement deposition in leucocortical lesions of marmoset EAE but not in subpial lesions.
14 Other studies have suggested that subpial demyelination occurs due to inflammation behind an intact blood brain barrier or a substance diffusing from inflammatory cells in the subarachnoid space. 3, 5, 38 Previous work has shown a diffuse 13-21% loss of cortical thickness in this model that was not directly related to local cortical lesions. 16 In this study, astrocyte staining was increased and oligodendrocyte loss was specific to demyelinated lesions implying that it is neuronal changes which are the substrate of cortical atrophy. We found evidence of a diffuse decrease in neuronal size and synaptic density in deep cortical layers. A similar decrease in cortical size and synaptic density was seen in superficial layers but these changes did not reach clinical significance in this study. We can speculate that it is a decrease in neuronal size related to axonal or dendritic loss which leads to cortical atrophy but further work is needed to confirm this.
An alternative explanation is that the methodology employed in this study has failed to detect a true neuronal loss in the model. We used cell profile counts that were corrected for any differences in the size of objects being counted by using the Abercrombie correction. Whilst the ratio of the section thickness to the object being counted was too high at 1 : 3 to produce cell density figures that could be compared across other studies we believe that the use of this correction prevented a systematic bias when comparing counts in matched areas within this current work. In addition, any error produced by a tendency to underestimate the density of smaller objects would have led us to overestimate the magnitude of diffuse neuronal loss as neurones were smaller in EAE cortex. Where it was possible, we compared parameters in lesions with matched areas of NAGM taken from an identical location in the opposite hemisphere of the same animal. As cingulate subpial lesions were always bilateral, it was not possible to use this method and indirect comparisons were used instead. This alternative will necessarily have introduced random error into the figures and reduced the power of the study to find significant differences between subpial lesions and control areas.
This study has described and quantified extensive neurodegenerative features in marmoset EAE and demonstrated that they occur in the early active stages of demyelinating disease. Focal, demyelinating cortical lesions are associated with some of these features whilst others have a more diffuse distribution and may be secondary to distant inflammatory lesions, diffuse inflammation in the cortex or an as yet unidentified neurodegenerative processes. Whilst there are important differences, the nature of the cortical pathology in marmoset EAE is similar to that of MS, suggesting that it is a good model with which to address questions related to GM injury in MS.
